Sign Up Today and Learn More About Twist Bioscience Stock

Invest in or calculate the value of your shares in Twist Bioscience or other pre-IPO companies through EquityZen's platform.

Get Started

Twist Bioscience Stock

Synthetic DNA production for specialty chemical compounds and drug development Twist Bioscience Corp.

About Twist Bioscience Stock

Founded

2013

Headquarters

San Francisco, CA, US

Total Funding

253M

At Twist Bioscience Corporation, they work in service of customers who are changing the world for the better. In fields such as health care, agriculture, industrial chemicals and data storage, by using our synthetic DNA tools, their customers are developing ways to better lives and improve the sustainability of the planet. They believe that the faster their customers succeed, the better for all of them , and Twist Bioscience is uniquely positioned to help accelerate their efforts. Their innovative silicon-based DNA Synthesis Platform provides precision at a scale that we believe is otherwise unavailable to their customers. their platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis and sequencing, providing both the quality and quantity of the tools they need to rapidly realize the opportunity ahead.

Twist Bioscience Press Mentions

Stay in the know about the latest news on Twist Bioscience

Twist Bioscience Management

Leadership team at Twist Bioscience

CFO

Solange Glaize

Founder & Chief Technology Officer

Bill Peck

Locked Features

Join now and verify your accreditation status to gain access to:

  • Twist Bioscience current valuation
  • Twist Bioscience stock price
  • Available deals in Twist Bioscience and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Twist Bioscience stock?

Accredited investors can buy pre-IPO stock in companies like Twist Bioscience through EquityZen funds. These investments are made available by existing Twist Bioscience shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Twist Bioscience stock?

Shareholders can sell their Twist Bioscience stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."